0.9111779447320654		SimpleArgument(wound care practitioners,List([131, 155)))	Relation(to address,List([156, 166)))	SimpleArgument(the entire spectrum of challenges,List([167, 200)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.9052256377408016		SimpleArgument(advanced wound care solutions,List([84, 113)))	Relation(will enable wound care practitioners to,List([119, 130), [131, 155), [156, 158)))	SimpleArgument(address the entire spectrum of challenges,List([159, 200)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.9052256377408016		SimpleArgument(advanced wound care solutions,List([84, 113)))	Relation(will enable,List([119, 130)))	SimpleArgument(wound care practitioners,List([131, 155)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.8942434158739456		SimpleArgument(clinicians,List([131, 141)))	Relation(to address,List([142, 152)))	SimpleArgument(the entire spectrum of challenges,List([153, 186)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.9052256377408016		SimpleArgument(advanced wound care solutions,List([84, 113)))	Relation(will enable clinicians to,List([119, 130), [131, 141), [142, 144)))	SimpleArgument(address the entire spectrum of challenges,List([145, 186)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.9052256377408016		SimpleArgument(advanced wound care solutions,List([84, 113)))	Relation(will enable,List([119, 130)))	SimpleArgument(clinicians,List([131, 141)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.8942434158739456		SimpleArgument(challenges,List([174, 184)))	Relation(presented by,List([185, 194), [195, 197)))	SimpleArgument(advanced wounds,List([198, 213)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.8942434158739456		SimpleArgument(challenges,List([174, 184)))	Relation(presented by,List([185, 194), [195, 197)))	SimpleArgument(chronic wounds,List([198, 212)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.8942434158739456		SimpleArgument(surgeons,List([131, 139)))	Relation(to address,List([140, 150)))	SimpleArgument(the entire spectrum of challenges,List([151, 184)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.9052256377408016		SimpleArgument(advanced wound care solutions,List([84, 113)))	Relation(will enable surgeons to,List([119, 130), [131, 139), [140, 142)))	SimpleArgument(address the entire spectrum of challenges,List([143, 184)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.9052256377408016		SimpleArgument(advanced wound care solutions,List([84, 113)))	Relation(will enable,List([119, 130)))	SimpleArgument(surgeons,List([131, 139)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.9143456855143793		SimpleArgument(Alliqua BioMedical,List([0, 18)))	Relation(is developing,List([59, 72)))	SimpleArgument(a suite of advanced wound care solutions,List([73, 113)))	Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds.
0.7440871846369149		SimpleArgument(its through distribution agreements with strategic partners,List([43, 102)))	Relation(include,List([108, 115)))	SimpleArgument(Celgene Cellular Therapeutics,List([116, 145)))	Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
0.7440871846369149		SimpleArgument(its through distribution agreements with strategic partners,List([43, 102)))	Relation(include,List([108, 115)))	SimpleArgument(Co. KG,List([116, 122)))	Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
0.38089450366724514		SimpleArgument(Celgene Cellular Therapeutics,List([113, 142)))	Relation([is] a subsidiary of,List([145, 160)))	SimpleArgument(Celgene Corporation,List([161, 180)))	Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
0.7440871846369149		SimpleArgument(its through licensing agreements with strategic partners,List([43, 99)))	Relation(include,List([105, 112)))	SimpleArgument(Celgene Cellular Therapeutics,List([113, 142)))	Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
0.7440871846369149		SimpleArgument(its through licensing agreements with strategic partners,List([43, 99)))	Relation(include,List([105, 112)))	SimpleArgument(Co. KG,List([113, 119)))	Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
0.9045207649554154		SimpleArgument(strategic partners,List([81, 99)))	Relation(include,List([105, 112)))	SimpleArgument(sorbion GmbH,List([113, 125)))	Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
0.9197759696552441		SimpleArgument(Alliqua,List([0, 7)))	Relation(is building,List([8, 19)))	SimpleArgument(this portfolio,List([20, 34)))	Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
0.9572029669433457		SimpleArgument(Alliqua's contract manufacturing business unit,List([0, 46)))	Relation(provides custom hydrogels to,List([47, 55), [56, 72), [73, 75)))	SimpleArgument(the OEM market,List([76, 90)))	Alliqua's contract manufacturing business unit provides custom hydrogels to the OEM market.
0.9489461080096143		SimpleArgument(Alliqua's contract manufacturing business unit,List([0, 46)))	Relation(provides,List([47, 55)))	SimpleArgument(custom hydrogels,List([56, 72)))	Alliqua's contract manufacturing business unit provides custom hydrogels to the OEM market.
0.9382554258342916		SimpleArgument(The Company,List([0, 11)))	Relation(is headquartered in,List([12, 28), [29, 31)))	SpatialArgument(Langhorne,List([32, 41)))	The Company is headquartered in Langhorne, PA.
